Health Care

Tilray CFO’s insider trades show confidence and tax‑efficient PSU use, hinting at long‑term growth amid volatile cannabis‑beer market.

Guardant Health insider moves reveal a subtle shift: CEO Eltoukhy Helmy sells and buys shares while boosting philanthropic trust and advancing liquid biopsy pipeline, signaling steady long‑term confidence.

Insider sales by Meister Keith at Illumina show a steady, walk‑through pattern—about 150 k shares at ~$226—while the stock climbs its 52‑week high, hinting at routine portfolio tweaks rather than panic.

Mark Hancock’s recent insider selling at PACS Group reveals a strategic portfolio realignment amid a strong market position, raising investor curiosity about future moves.

Insider selling at Hinge Health rises—Robinson Elliott’s recent $92.85 sale signals routine liquidity, not a crisis, while the company’s robust growth keeps investors intrigued.

HealthEquity insider trades show disciplined growth: director buys low, sells near market, reinforcing confidence in its tech‑driven health‑care value.

Insider sale of 56,500 Centene shares by Koster shows routine liquidity moves, not a warning. Stay tuned for earnings to gauge future outlook.

Insider liquidations after Forte’s merger into argenx clear the way for a unified oncology platform. Learn how regulatory compliance drives market liquidity, ownership reset, and the strategic upside for investors.

Inside Corcept Therapeutics: Sean Maduck’s $11.35 purchase vs. $125 option sale—insider confidence, liquidity strategy and potential short‑term volatility.

Envista insider sales on 8/25/26 show routine tax‑trigger moves, not distress—dental market stays bullish, product pipeline fuels growth.